SEC Form 4 · accession 0001209191-17-025162
Armata Pharmaceuticals, Inc. · ARMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven Robert Martin
Officer — Chief Financial Officer
Period of report
Apr 1, 2017
Accepted (ET)
Apr 4, 2017 · 5:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921114
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $0.43 | Apr 1, 2017 | A | 161,290 | A | — | Mar 31, 2021 | Common Stock | 161,290 | 161,290 | D |
Explanation of responses
- F1The shares subject to the option are 100% vested and exercisable as of the date of grant.